Akèy › Kasinom Selil Transizyonèl (Urotelyal) › Texas › Tyler
Etid klinik pou Kasinom Selil Transizyonèl (Urotelyal) nan Tyler, TX
4 etid pou Kasinom Selil Transizyonèl (Urotelyal) ap chèche patisipan nan sit nan ak bò kote Tyler (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Ap rekriteFaz 1
- Exelixis Clinical Site #70, Tyler
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Ap rekriteFaz 3
- Texas Oncology - Northeast Texas, Tyler
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Ap rekriteFaz 3
- USO - Texas Oncology - Northeast Texas, Tyler
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Ap rekriteFaz 1/2
- The University of Texas Health Science Center at Tyler, Tyler
Etid Kasinom Selil Transizyonèl (Urotelyal) nan lòt vil
- Nashville, TN23 etid
- New York City, NY22 etid
- Dallas, TX18 etid
- Edison, NJ18 etid
- Houston, TX18 etid
- Los Angeles, CA17 etid
- Queens, NY15 etid
- Chicago, IL14 etid
- Arlington, VA12 etid
- San Antonio, TX11 etid
- Boston, MA11 etid
- Austin, TX10 etid
Lòt etid nan Tyler
- Kansè Poumon ki pa ti selil20 etid
- Maladi Crohn16 etid
- Kolit Ulseratif14 etid
- Kansè kolorektal8 etid
- Ensifizyans kadyak8 etid
- Kansè (tout kalite)7 etid
- Kansè ovè7 etid
- Kansè Endomèt6 etid
- Karsinòm selil skuamèz tèt ak kou6 etid
- Kansè nan tete6 etid
- Kansè Metastatik5 etid
- Maladi Entestinal Anflamatwa5 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.